Aims and scope of journal
Neuropsychopharmacology is an international scientific journal and the official publication of the American College of Neuropsychopharmacology (ACNP). This journal focuses on clinical and basic science contributions that advance our understanding of the brain and behaviour, especially as related to the molecular, cellular, physiological and psychological properties of agents acting within the central nervous system and the identification of the new molecular targets for the development of the next generation of drugs. While original reports are preferred, mini-reviews and perspectives are invited by the editorial office. In view of the interdisciplinary nature of the field, particular emphasis is placed on:
- studies that advance the biological bases of normal and pathological behavior
- the nature, etiology and pathophysiology of neuropsychiatric disorders
- biologically relevant aspects of the epidemiology, diagnosis, and treatment of these disorders
- and the basic mechanisms by which psychopharmacological agents exert their effect
Our publishing models
Neuropsychopharmacology is a Transformative Journal (TJ). When research is accepted for publication, authors can choose to publish using either the traditional publishing route OR via immediate gold Open Access.
Neuropsychopharmacology is actively committed to becoming a fully Open Access journal. We will increase the number of articles we publish OA, with the eventual goal of becoming a fully Open Access journal. A journal that commits to this process is known as a Transformative Journal.
Authors may need to take specific actions to achieve compliance with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route our standard licensing terms will need to be accepted including our self-archiving policies. Those standard licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript.
The 2020 journal citation metrics for Neuropsychopharmacology are as follows:
2-year Impact Factor*: 7.853
5-year Impact Factor*: 8.209
Immediacy index*: 2.126
Eigenfactor® score*: 0.0346
Article influence score*: 2.571
JCR Rank*: PHARMACOLOGY & PHARMACY 13/275; PSYCHIATRY 14/156
Journal Citation Score*: 1.98
*2020 Journal Citation Reports® Science Edition (Clarivate Analytics, 2020)
Benefits of Publishing with Neuropsychopharmacology
Online presence - reducing publication times
Neuropsychopharmacology has adopted Springer Nature's online submission system, which allows authors to submit papers via the Web. Speeding up the submission and refereeing process, this system also allows you to view the status of your paper online.
Weekly publication online
New articles in Neuropsychopharmacology, as in all Springer Nature journals, are published weekly online ahead of the archival print issue, ensuring the research is made publicly available and can be cited as soon as possible after acceptance for publication. The online publication is identical to the printed version and is not a preliminary, unedited version, thus maintaining the journal's tradition of excellence and the integrity of the published record.
Supplementary online material
Authors are invited to submit additional supporting material such as data sets or video for publication in the online version of the journal. Online supplementary material makes the most of the Web as a delivery platform and can often give articles greater depth, making them more useful to readers.
Authors who choose to publish in any Springer Nature journal can be assured that its staff's publishing, editorial and production skills are committed to maintaining the highest possible quality and standards.
Exposure - widest possible readership
All Springer Nature journals including Neuropsychopharmacology, are available online via site licenses to academic, corporate and government institutions and consortia. Journals are available to members of these institutions at the click of a mouse, adding speed and visibility to authors' research papers.
Regular free e-mail alerts
Content published in Neuropsychopharmacology has the potential to reach scientists around the world who have signed up for Springer Nature's free table of contents e-alerts, ensuring additional exposure to authors. These e-alerts allow recipients to click through to the full article if they subscribe or work at an institution with a site license, or click through to the article's abstract for other readers.
Focused subject areas on nature.com
From immunology to physics, genetics to materials, subject-specific areas provide a focused environment for readers, providing a monthly updated focus for a particular field.
Abstracting and indexing
Neuropsychopharmacology is included in the leading abstracting and indexing services including ISI, MEDLINE, EMBASE and BIOSIS. Extensive reference linking to MEDLINE, ISI, Chemport and others via services such as Crossref and DOI numbers provide seamless online linking between articles and databases.
The Nature press office provides information about exceptionally interesting papers published throughout Springer Nature. More than 2,000 journalists and media organizations worldwide subscribe to the press service, ensuring that papers receive maximum exposure in the world's most important media channels including newspapers, magazines, radio and television.
Extending science further - global collaborations
Spinger Nature and Neuropsychopharmacology support some projects aimed at making current research available to a broader community of scientists and practitioners.
All Springer Nature journals, including Neuropsychopharmacology, are in WHO's HINARI (Health InterNetwork Access to Research Initiative) program, which provides free access to public institutions in developing countries.
Global News Media
ISSN and eISSN
The international standard serial number (ISSN) for Neuropsychopharmacology is 0893-133X and the electronic international standard serial number (eISSN) is 1740-634X.
Neuropsychopharmacology now provides its latest table of contents as an RSS web feed. This allows users with an RSS reader to receive automatic updates whenever new content is added to these pages.
Find out more about RSS feeds, how to download an RSS reader and see all the news feeds offered by Springer Nature.